Global Ulcerative Colitis Market By Drug Type (Aminosalicylates, Corticosteroids, Immunomodulators, Biologics (Anti-TNF, Anti-Integrin, Anti-IL-23), JAK Inhibitors, Others) By Route of Administration (Oral, Injectable, Others) By End User (Hospitals, Specialty Clinics (Gastroenterology), Homecare Settings, Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035
- Published date: June 2026
- Report ID: 187211
- Number of Pages: 387
- Format:
-
keyboard_arrow_up
-
-
- AbbVie Inc.
- Johnson & Johnson
- Pfizer Inc.
- Takeda Pharmaceutical Company Limited
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Novartis AG
- Merck & Co., Inc.
- Amgen Inc.
- UCB S.A.
- Celgene Corporation (BMS)
- AstraZeneca plc
- Ferring Pharmaceuticals
- Salix Pharmaceuticals
- Others
Our Clients
- 187211
- June 2026
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
